Molecular mechanisms of antibiotic resistance

JMA Blair, MA Webber, AJ Baylay, DO Ogbolu… - Nature reviews …, 2015 - nature.com
Antibiotic-resistant bacteria that are difficult or impossible to treat are becoming increasingly
common and are causing a global health crisis. Antibiotic resistance is encoded by several …

Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options

YT Chang, CY Lin, YH Chen, PR Hsueh - Frontiers in microbiology, 2015 - frontiersin.org
Stenotrophomonas maltophilia is a Gram-negative, biofilm-forming bacterium. Although
generally regarded as an organism of low virulence, S. maltophilia is an emerging multi …

A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics

P Sarkar, V Yarlagadda, C Ghosh, J Haldar - Medchemcomm, 2017 - pubs.rsc.org
Cell wall biosynthesis inhibitors (CBIs) have historically been one of the most effective
classes of antibiotics. They are the most extensively used class of antibiotics and their …

Task force on management and prevention of Acinetobacter baumannii infections in the ICU

J Garnacho-Montero, G Dimopoulos, G Poulakou… - Intensive care …, 2015 - Springer
Introduction Acinetobacter baumannii constitutes a dreadful problem in many ICUs
worldwide. The very limited therapeutic options available for these organisms are a matter of …

Antimicrobial Treatment Strategies for Stenotrophomonas maltophilia: A Focus on Novel Therapies

J Gibb, DW Wong - Antibiotics, 2021 - mdpi.com
Stenotrophomonas maltophilia is an urgent global threat due to its increasing incidence and
intrinsic antibiotic resistance. Antibiotic development has focused on carbapenem-resistant …

Recent advances and perspectives in the design and development of polymyxins

F Rabanal, Y Cajal - Natural product reports, 2017 - pubs.rsc.org
Covering: 1947-early 2017, particularly from 2005-early 2017 The rise of bacterial
pathogens with acquired resistance to almost all available antibiotics is becoming a serious …

Battle against vancomycin-resistant bacteria: recent developments in chemical strategies

G Dhanda, P Sarkar, S Samaddar… - Journal of medicinal …, 2018 - ACS Publications
Vancomycin, a natural glycopeptide antibiotic, was used as the antibiotic of last resort for the
treatment of multidrug-resistant Gram-positive bacterial infections. However, almost 30 years …

Emerging roles of glycopeptide antibiotics: Moving beyond gram-positive bacteria

Y Acharya, S Bhattacharyya, G Dhanda… - ACS Infectious …, 2021 - ACS Publications
Glycopeptides, a class of cell wall biosynthesis inhibitors, have been the antibiotics of choice
against drug-resistant Gram-positive bacterial infections. Their unique mechanism of action …

In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: a systematic review and meta-analysis

W Ni, X Shao, X Di, J Cui, R Wang, Y Liu - International journal of …, 2015 - Elsevier
In order to provide preliminary guidance for rational antibiotic combination therapy in the
clinic, a systematic review and meta-analysis was performed to evaluate the in vitro …

Synergistic combinations of polymyxins

JR Lenhard, RL Nation, BT Tsuji - International journal of antimicrobial …, 2016 - Elsevier
The proliferation of extensively drug-resistant Gram-negative pathogens has necessitated
the therapeutic use of colistin and polymyxin B. However, treatment failures with polymyxin …